Clinical and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics
Patients-reported Outcome Measures (PROMs), Clinical Objective and Biomolecular Assessment for the Monitoring of Patients Undergoing Regenerative Medicine Treatments with Orthobiologics
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
2,000 participants
May 30, 2018
OBSERVATIONAL
Conditions
Summary
the aim is to improve the evaluation of the outcomes of regenerative medicine treatments performed in the regenerative medicine centers involved in the study. patients who undergo regenerative medicine treatments present acute and chronic pathologies of the musculoskeletal system, of the stomatological system and of the integuments. Objective pre, peri and post treatment evaluations are collected. A dedicated software collects the PROMs compiled by the patients, the objective clinical data and the biomolecular evaluations.
Eligibility
Inclusion Criteria3
- patients who received indication for regerative medicine treatment for one of the following pathologies: Knee or hip or ankle osteoarthritis, patellar or Achilles tendon pain, shouder or elbow pain;
- males and females;
- age \>= 6 years.
Exclusion Criteria3
- age \< 6 years
- patients not compliant with post-treatment monitoring procedures
- pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PRP and related devices to abtain platelet concentrate from whole blood, medullary and adipose tissue and related devices
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04711551